Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Crit Care Med. 2011 May;39(5):961-6. doi: 10.1097/CCM.0b013e318208ee26.
Selective digestive tract decontamination aims to eradicate gram-negative bacteria in both the intestinal tract and respiratory tract and is combined with a 4-day course of intravenous cefotaxime. Selective oropharyngeal decontamination only aims to eradicate respiratory tract colonization. In a recent study, selective digestive tract decontamination and selective oropharyngeal decontamination were associated with lower day-28 mortality, when compared to standard care. Furthermore, selective digestive tract decontamination was associated with a lower incidence of intensive care unit-acquired bacteremia caused by gram-negative bacteria. We quantified the role of intestinal tract carriage with gram-negative bacteria and intensive care unit-acquired gram-negative bacteremia.
Data from a cluster-randomized and a single-center observational study.
Intensive care unit in The Netherlands.
Patients with intensive care unit stay of >48 hrs that received selective digestive tract decontamination (n = 2,667), selective oropharyngeal decontamination (n = 2,166) or standard care (n = 1,945).
Selective digestive tract decontamination or selective oropharyngeal decontamination.
Incidence densities (episodes/1000 days) of intensive care unit-acquired gram-negative bacteremia were 4.5, 3.0, and 1.4 during standard care, selective oropharyngeal decontamination, and selective digestive tract decontamination, respectively, and the daily risk for developing intensive care unit-acquired gram-negative bacteria bacteremia increased until days 36, 33, and 31 for selective digestive tract decontamination, standard care, and selective oropharyngeal decontamination and was always lowest during selective digestive tract decontamination. Rectal colonization with gram-negative bacteria was present in 26% and 71% of patient days during selective digestive tract decontamination and selective oropharyngeal decontamination, respectively (p < .01). Irrespective of interventions, incidence densities of intensive care unit-acquired gram-negative bacteremia was 4.5 during patient days with both intestinal and respiratory tract gram-negative bacteria carriage. These incidence densities reduced with 33% (to 3.1) during days with intestinal gram-negative bacteria carriage only and with another 45% (to 1.0) during days without gram-negative bacteria carriage at both sites.
Respiratory tract decolonization was associated with a 33% and intestinal tract decolonization was associated with a 45% reduction in the occurrence of intensive care unit-acquired gram-negative bacteremia.
选择性消化道去污旨在根除肠道和呼吸道中的革兰氏阴性菌,并结合静脉头孢噻肟治疗 4 天。选择性口咽去污仅旨在根除呼吸道定植。最近的一项研究表明,与标准护理相比,选择性消化道去污和选择性口咽去污可降低第 28 天的死亡率。此外,选择性消化道去污与由革兰氏阴性菌引起的 ICU 获得性菌血症的发生率降低有关。我们量化了肠道携带革兰氏阴性菌和 ICU 获得性革兰氏阴性菌血症的作用。
来自一项集群随机和一项单中心观察性研究的数据。
荷兰的 ICU。
入住 ICU 超过 48 小时并接受选择性消化道去污(n = 2667)、选择性口咽去污(n = 2166)或标准护理(n = 1945)的患者。
选择性消化道去污或选择性口咽去污。
标准护理、选择性口咽去污和选择性消化道去污期间 ICU 获得性革兰氏阴性菌血症的发生率密度(每 1000 天发生的病例数)分别为 4.5、3.0 和 1.4,选择性消化道去污、标准护理和选择性口咽去污的 ICU 获得性革兰氏阴性菌血症的日发病风险分别在第 36、33 和 31 天达到峰值,并且在选择性消化道去污期间始终最低。选择性消化道去污和选择性口咽去污期间,直肠革兰氏阴性菌定植分别占患者日的 26%和 71%(p <.01)。无论干预措施如何,在肠道和呼吸道均存在革兰氏阴性菌定植的患者日,ICU 获得性革兰氏阴性菌血症的发生率密度为 4.5。仅在肠道革兰氏阴性菌定植的情况下,发生率密度降低了 33%(至 3.1),而在两个部位均无革兰氏阴性菌定植的情况下,发生率密度又降低了 45%(至 1.0)。
呼吸道去定植与 ICU 获得性革兰氏阴性菌血症的发生减少 33%有关,而肠道去定植与 ICU 获得性革兰氏阴性菌血症的发生减少 45%有关。